JPY 478.0
(5.05%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 4.85 Billion | 5.55 Billion | 3.9 Billion | 2.61 Billion |
Cost of Revenue | 2.1 Billion | 2.62 Billion | 1.54 Billion | 1.19 Billion |
Gross Profit | 2.75 Billion | 2.93 Billion | 2.35 Billion | 1.42 Billion |
Operating Expenses | 2.46 Billion | 2.03 Billion | 1.66 Billion | 1.26 Billion |
Selling, General and Administrative Expenses | 2.39 Billion | 1.99 Billion | 1.63 Billion | 1.4 Billion |
Research and Development Expenses | - | - | - | - |
Other Expenses | - | 5.66 Million | 9.31 Million | 18.03 Million |
Cost and Expenses | 4.56 Billion | 4.65 Billion | 3.21 Billion | 2.45 Billion |
Operating Income | 289.2 Million | 907.66 Million | 687.66 Million | 157.44 Million |
Interest Expense | - | 14.62 Million | 6.69 Million | 3.8 Million |
Income Tax Expense | 101.42 Million | 288.64 Million | 7.25 Million | 8.73 Million |
Earnings before Tax | 292.29 Million | 898.46 Million | 689.24 Million | -293.51 Million |
Net Income | 190.87 Million | 609.82 Million | 681.99 Million | -302.24 Million |
Earnings Per Share Basic | 31.42 | 110.58 | 127.71 | -56.60 |
Earnings Per Share Diluted | 31.40 | 110.25 | 127.71 | -49.76 |
Weighted Average Shares Outstanding | 6.07 Million | 5.51 Million | 5.34 Million | 5.34 Million |
Weighted Average Shares Outstanding (Diluted) | 6.07 Million | 5.53 Million | 5.34 Million | 6.07 Million |
Gross Margin | 0.57 | 0.53 | 0.60 | 0.54 |
EBIT Margin | 0.07 | 0.17 | 0.19 | -0.04 |
Profit Margin | 0.04 | 0.11 | 0.17 | -0.12 |
EBITDA | 357.38 Million | 943.14 Million | 730.53 Million | -222.48 Million |
Earnings Before Tax Margin | 0.06 | 0.16 | 0.18 | 0.06 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 1.06 Billion | 1.22 Billion | 1.02 Billion | 4.85 Billion | 1.29 Billion | 1.12 Billion |
Cost of Revenue | 440.25 Million | 525.81 Million | 420.77 Million | 2.1 Billion | 538.91 Million | 462.17 Million |
Gross Profit | 627.56 Million | 699.47 Million | 608.55 Million | 2.75 Billion | 757.48 Million | 665.84 Million |
Operating Expenses | 584.6 Million | 654.88 Million | 688.76 Million | 2.46 Billion | 587.36 Million | 641.49 Million |
Selling, General and Administrative Expenses | 584.6 Million | 632.57 Million | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 1.52 Million | 11 Thousand | 413 Thousand | 3.23 Million | 33 Thousand | 2.47 Million |
Cost and Expenses | 1.02 Billion | 1.18 Billion | 1.1 Billion | 4.56 Billion | 1.12 Billion | 1.1 Billion |
Operating Income | 42.95 Million | 44.58 Million | -80.2 Million | 289.2 Million | 170.11 Million | 24.34 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 19.39 Million | 16.33 Million | -32.67 Million | 101.42 Million | 63.15 Million | 12.21 Million |
Earnings before Tax | 47.88 Million | 43.41 Million | -80.33 Million | 292.29 Million | 169.56 Million | 27.84 Million |
Net Income | 28.49 Million | 27.07 Million | -47.66 Million | 190.87 Million | 106.41 Million | 15.63 Million |
Earnings Per Share Basic | 4.68 | 4.46 | -7.85 | - | 17.52 | 2.57 |
Earnings Per Share Diluted | 4.68 | 4.46 | -7.85 | - | 17.50 | 2.57 |
Weighted Average Shares Outstanding | 6.08 Million | 6.07 Million | 6.07 Million | 6.07 Million | 6.07 Million | 6.08 Million |
Weighted Average Shares Outstanding (Diluted) | 6.08 Million | 6.07 Million | 6.07 Million | 6.07 Million | 6.08 Million | 6.08 Million |
Gross Margin | 0.59 | 0.57 | 0.59 | 0.57 | 0.58 | 0.59 |
EBIT Margin | 0.06 | 0.04 | -0.08 | - | 0.13 | 0.02 |
Profit Margin | 0.03 | 0.02 | -0.05 | 0.04 | 0.08 | 0.01 |
EBITDA | 66.67 Million | 44.58 Million | -80.2 Million | - | 170.12 Million | 24.34 Million |
Earnings Before Tax Margin | 0.04 | 0.04 | -0.08 | 0.06 | 0.13 | 0.02 |
CLN
ALFUW
RDX
MEDX
ALD
RSI